n(g),n(g')-dimethyl-l-arginine has been researched along with Diabetic Neuropathies in 3 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of the meta-analysis was to evaluate the relationship between serum asymmetric dimethylarginine (ADMA) level and microvascular complications in diabetes mellitus (DM) including diabetic retinopathy (DR), diabetic neuropathy (DN), and diabetic nephropathy." | 9.01 | Relationship between Serum Asymmetric Dimethylarginine Level and Microvascular Complications in Diabetes Mellitus: A Meta-Analysis. ( Chen, W; He, K; Li, C; Liu, J; Ma, B; Ma, H; Tian, L; Zhao, P, 2019) |
| "The purpose of the meta-analysis was to evaluate the relationship between serum asymmetric dimethylarginine (ADMA) level and microvascular complications in diabetes mellitus (DM) including diabetic retinopathy (DR), diabetic neuropathy (DN), and diabetic nephropathy." | 5.01 | Relationship between Serum Asymmetric Dimethylarginine Level and Microvascular Complications in Diabetes Mellitus: A Meta-Analysis. ( Chen, W; He, K; Li, C; Liu, J; Ma, B; Ma, H; Tian, L; Zhao, P, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, J | 1 |
| Li, C | 1 |
| Chen, W | 1 |
| He, K | 1 |
| Ma, H | 1 |
| Ma, B | 1 |
| Zhao, P | 1 |
| Tian, L | 1 |
| Yaşar, H | 1 |
| Senol, MG | 1 |
| Kendirli, T | 1 |
| Önem, Y | 1 |
| Özdağ, F | 1 |
| Saraçoğlu, M | 1 |
| El-Mesallamy, HO | 1 |
| Hamdy, NM | 1 |
| Ezzat, OA | 1 |
| Reda, AM | 1 |
1 review available for n(g),n(g')-dimethyl-l-arginine and Diabetic Neuropathies
| Article | Year |
|---|---|
Relationship between Serum Asymmetric Dimethylarginine Level and Microvascular Complications in Diabetes Mellitus: A Meta-Analysis.
Topics: Arginine; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; D | 2019 |
2 other studies available for n(g),n(g')-dimethyl-l-arginine and Diabetic Neuropathies
| Article | Year |
|---|---|
Serum asymmetric dimethylarginine levels in diabetic patients with neuropathy.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Diabetic Neuropathies; Electrophysiology; Female; Humans; | 2011 |
Levels of soluble advanced glycation end product-receptors and other soluble serum markers as indicators of diabetic neuropathy in the foot.
Topics: Aged; Arginine; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Foot; Diabetic Neuropathies; Glycate | 2011 |